BlueCrest Capital Management Ltd decreased its stake in Stericycle, Inc. (NASDAQ:SRCL) by 58.7% during the first quarter, Holdings Channel reports. The fund owned 10,475 shares of the business services provider’s stock after selling 14,909 shares during the period. BlueCrest Capital Management Ltd’s holdings in Stericycle were worth $868,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in SRCL. BlackRock Inc. boosted its position in Stericycle by 3,492.3% in the first quarter. BlackRock Inc. now owns 5,089,580 shares of the business services provider’s stock valued at $421,877,000 after buying an additional 4,947,900 shares during the last quarter. FMR LLC boosted its position in Stericycle by 84.8% in the fourth quarter. FMR LLC now owns 2,704,145 shares of the business services provider’s stock valued at $208,327,000 after buying an additional 1,240,853 shares during the last quarter. Ameriprise Financial Inc. boosted its position in Stericycle by 144.9% in the first quarter. Ameriprise Financial Inc. now owns 1,901,243 shares of the business services provider’s stock valued at $157,594,000 after buying an additional 1,124,908 shares during the last quarter. Norges Bank acquired a new position in Stericycle during the fourth quarter valued at about $59,797,000. Finally, Wedge Capital Management L L P NC acquired a new position in Stericycle during the first quarter valued at about $43,949,000. Institutional investors own 96.51% of the company’s stock.
Shares of Stericycle, Inc. (NASDAQ SRCL) opened at 77.08 on Wednesday. The firm has a market cap of $6.57 billion, a PE ratio of 40.17 and a beta of 0.15. The firm’s 50-day moving average price is $82.42 and its 200-day moving average price is $80.72. Stericycle, Inc. has a one year low of $71.52 and a one year high of $107.74.
Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, May 4th. The business services provider reported $1.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Stericycle had a return on equity of 14.40% and a net margin of 5.23%. The firm had revenue of $892.40 million for the quarter, compared to analysts’ expectations of $874.34 million. During the same quarter in the previous year, the company earned $1.11 earnings per share. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. Equities research analysts expect that Stericycle, Inc. will post $4.63 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was first posted by sleekmoney and is the property of of sleekmoney. If you are reading this article on another publication, it was copied illegally and reposted in violation of US and international copyright laws. The original version of this article can be read at https://sleekmoney.com/stericycle-inc-srcl-shares-sold-by-bluecrest-capital-management-ltd/1946203.html.
Several equities analysts have issued reports on SRCL shares. Robert W. Baird cut Stericycle from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $74.00 to $73.00 in a research report on Friday, May 5th. Deutsche Bank AG lowered their price target on Stericycle from $14.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, May 15th. Jefferies Group LLC set a $108.00 price target on Stericycle and gave the stock a “buy” rating in a report on Thursday, March 16th. Barclays PLC began coverage on Stericycle in a report on Thursday, April 13th. They issued an “overweight” rating and a $100.00 price target on the stock. Finally, Zacks Investment Research cut Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, May 2nd. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $82.17.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL).
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/stericycle-inc-srcl-shares-sold-by-bluecrest-capital-management-ltd/1946203.html
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.